Alexander Asamoah is a Rare/Genetic physician affiliated with University of Louisville. OpenAlex indexes 73 publications with 2,772 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
411 E Chestnut St # Street2
Louisville, KY 402021713
Telephone
502-588-0850Provider last certified this registry record 14 Feb 2022.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ultragenyx Pharmaceutical Inc.Program year20232 payments
- Rhythm Pharmaceuticals, Inc.Program year20231 payment
- Ultragenyx Pharmaceutical Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme100%Fabrazyme100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Recurrent de novo<i>SPTLC2</i>variant causes childhood-onset amyotrophic lateral sclerosis (ALS) by excess sphingolipid synthesis
Journal of Neurology Neurosurgery & Psychiatry
2023 - Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana
Frontiers in Cellular and Infection Microbiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Kelly McMasters, MD
University of Louisville
Stephen McClave, MD
University of Louisville
Robert Friedland, MD
University of Louisville
Charles Scoggins, MD
University of Louisville
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”